| Patricia Taitt, MD | |
|
30 Columbia St, Poughkeepsie, NY 12601-3906 | |
| (845) 231-5600 | |
| (845) 592-7708 |
| Full Name | Patricia Taitt |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 17 Years |
| Location | 30 Columbia St, Poughkeepsie, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962727024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 257867 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus's propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 6 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus's propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Taitt, MD 110 S Bedford Rd, Caremount Medical Pc, Mount Kisco, NY 10549-3446 Ph: (914) 241-1050 | Patricia Taitt, MD 30 Columbia St, Poughkeepsie, NY 12601-3906 Ph: (845) 231-5600 |
News Archive
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus's propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 6 days ago
Joe Joseph, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-454-8500 | |
Arthur G Walczyk, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 159 Barnegat Rd Fl 2, Poughkeepsie, NY 12601 Phone: 845-452-9800 Fax: 845-452-7691 | |
Dr. Amelia Martinko, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 30 Columbia St, Poughkeepsie, NY 12601 Phone: 845-231-5600 Fax: 845-592-7708 | |
Dr. Nili Gujadhur, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9 Livingston St, Suite 4n, Poughkeepsie, NY 12601 Phone: 845-471-0232 | |
Paul D Burrows, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 159 Barnegat Rd Fl 2, Poughkeepsie, NY 12601 Phone: 845-452-9800 Fax: 845-452-7691 | |
Dr. Stuart Alan Feinstein, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 9 Livingston Street, Suite 4n, Poughkeepsie, NY 12601 Phone: 845-471-0232 Fax: 845-471-0267 | |
Dr. David S Cho, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 243 North Rd Ste 203, Poughkeepsie, NY 12601 Phone: 845-451-7271 |